3

PRIMARY DOCUMENT

Company: Actinium Pharmaceuticals, Inc.
Filed: January 3, 2013
Period of Report: December 28, 2012
Accession Number: 0001078782-13-000015

View Document ↗ View on SEC.gov ↗